Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4015 results

Sort By:

Decision Support Tool to Integrate PrEP Into Emergency Departments

Study ID: NCT07279129
Start Date: 2027-01-15
End Date: 2028-09-09
Study Type

Interventional

Study Phase

Phase1

No. of Participants

120

Intervention / Treatment

Decision support tool

PrEP Delivery

Sponsor

George Washington University

Source: clinicaltrials.gov

Share:
Add to list

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

Study ID: NCT07413939
Start Date: 2026-04-30
End Date: 2032-08-28
Study Type

Interventional

Study Phase

Phase3

No. of Participants

650

Intervention / Treatment

Ruhhhh 1950

Tucatinib

Trastuzumab

Capecitabine

Sponsor

Hoffmann-La Roche

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Study to Evaluate SM17 for Atopic Dermatitis

Study ID: NCT07445919
Start Date: 2026-04-05
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

200

Intervention / Treatment

SM17 for subcutaneous injection

SM17 placebo for subcutaneous injection

Sponsor

SinoMab BioScience Ltd

Source: clinicaltrials.gov

Share:
Add to list

Restrictive Versus Liberal Fluid Intake in Acute Decompensated Heart Failure

Study ID: NCT07400991
Start Date: 2026-05-01
End Date: 2029-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

420

Intervention / Treatment

Fluid restriction strategy

Thirst-driven, liberal fluid intake

Sponsor

Gødstrup Hospital

Source: clinicaltrials.gov

Share:
Add to list

A Study of AK104 (SC) in Combination With Oxaliplatin and Capecitabine (XELOX) Versus AK104 (IV) in Combination With XELOX in Participants With Unresectable Locally Advanced or Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

Study ID: NCT07449780
Start Date: 2026-03-31
End Date: 2028-02-15
Study Type

Interventional

Study Phase

Phase3

No. of Participants

422

Intervention / Treatment

AK104(SC)

AK104(IV)

Capecitabine

Oxaliplatin injection

Sponsor

It's coming

Source: clinicaltrials.gov

Share:
Add to list

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

Study ID: NCT07406087
Start Date: 2026-11-01
End Date: 2027-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

Adapted patient navigation program targeting adolescent and young adult cancer survivors

Sponsor

Kaiser Permanente

Source: clinicaltrials.gov

Share:
Add to list

The Preventive Risk Outreach And Cascade Testing

Study ID: NCT07478237
Start Date: 2026-06
End Date: 2029-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

Minimally facilitated platform

AI-powered platform

Sponsor

Stanford University

Source: clinicaltrials.gov

Share:
Add to list

Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoarthritis. (KOA PRP ACS)

Study ID: NCT07473232
Start Date: 2026-04-01
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Autologous Platelet-Rich Plasma (PRP)

Conditioned serum (CS)

Sponsor

Pamukkale University

Source: clinicaltrials.gov

Share:
Add to list

Perfusion Index and End Diastolic Velocity Ratios as Predictors of Supraclavicular Block Success in Vascular Access Surgery

Study ID: NCT07197281
Start Date: 2026-05-01
End Date: 2027-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment
Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Orthopedic Procedures and Postoperative Delirium in Older Adults in the Czech Republic

Study ID: NCT07432009
Start Date: 2026-04-01
End Date: 2030-03-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment
Sponsor

Tomas Bata Hospital, Czech Republic

Source: clinicaltrials.gov

Share:
Add to list